Abiopharma

Cavalier Jason 🔴 sold 769 shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007760

Palasis Maria 🔴 sold 1.7K shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007751

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Cellectis Announces 2026 Strategy and Catalysts

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 59 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $5K) Filed: Jan 08, 2026 | ID: 000225

New Form SCHEDULE 13D - IRIDEX CORP Filed: 2026-01-08 AccNo: 0002097627-26-000007 Size: 20 KB

📋 VanDuyn Amy Beth (Officer) plans to sell 3K shares of Phreesia, Inc. (at $17.01 each, total $44K) Filed: Jan 08, 2026 | ID: 000224

📋 Hoffman Allison C (Officer) plans to sell 7K shares of Phreesia, Inc. (at $17.01 each, total $112K) Filed: Jan 08, 2026 | ID: 000223

📋 Almstead Neil Gregory (Officer) plans to sell 881 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $67K) Filed: Jan 08, 2026 | ID: 000222

📋 Lyssikatos Joseph P (Officer) plans to sell 82K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $1.3M) Filed: Jan 08, 2026 | ID: 000005

📋 Heyman Richard A. (Director) plans to sell 2K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $25K) Filed: Jan 08, 2026 | ID: 000004

📋 LAURA A WILLIAMS (Officer) plans to sell 50K shares of ARDELYX INC (at $5.83 each, total $292K) Filed: Jan 08, 2026 | ID: 000286

📋 JOSEPH OLIVETO (Director) plans to sell 80K shares of MILESTONE PHARMACEUTICALS INC (at $2.15 each, total $171K) Filed: Jan 08, 2026 | ID: 000282